Caitong International Asset Management’s GeneDx Holdings WGS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-3,422
Closed -$220K – 3483
2026
Q1
$220K Buy
3,422
+2,585
+309% +$236K 0.04% 364
2025
Q4
$109K Buy
837
+815
+3,705% +$112K 0.03% 391
2025
Q3
$2.37K Buy
+22
New +$2.4K ﹤0.01% 1358
2025
Q2
– Sell
-21
Closed -$1.86K – 2540
2025
Q1
$1.86K Buy
+21
New +$1.82K ﹤0.01% 1376

Other funds holding WGS

Caitong International Asset Management's WGS Position: Q2 2026 in Review

Caitong International Asset Management sold out of GeneDx Holdings (WGS) in Q2 2026, closing a stake of 3,422 shares — an estimated $220K sold.

Caitong International Asset Management first reported a position in WGS in Q1 2025 and held it in 4 quarters. The position peaked at $220K in Q1 2026. 223 funds tracked by Wall St. Rank hold WGS as of Q2 2026.

  • Caitong International Asset Management reported no remaining GeneDx Holdings position as of Q2 2026 after selling out during the quarter.
  • Caitong International Asset Management sold 3,422 GeneDx Holdings shares in Q2 2026, an estimated $220K.
  • Caitong International Asset Management first reported a position in GeneDx Holdings in Q1 2025 and held it in 4 quarters.
  • Caitong International Asset Management's GeneDx Holdings position peaked at $220K in Q1 2026.
  • 223 funds tracked by Wall St. Rank held GeneDx Holdings as of Q2 2026.

Based on Caitong International Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.